The 'anomalous' absorption of labelled and unlabelled vitamin C in man.

Br J Nutr

MRC Human Nutrition Research, Fulbourn Road, Cambridge CB1 9NL, UK.

Published: May 2005

Previous studies of vitamin C absorption in man using stable isotope probes have given results which cannot easily be reconciled with those obtained using non-isotope measurement. In order to investigate some of the apparent paradoxes we have conducted a study using two consecutive doses of vitamin C, one labelled and one unlabelled, given 90 min apart. Compatibility of the experimental results with two feasible models was investigated. In Model 1, ingested vitamin C enters a pre-existing pool before absorption, which occurs only when a threshold is exceeded; in Model 2, ingested vitamin C is exchanged with a pre-existing flux before absorption. The key difference between these two models lies in the predicted profile of labelled material in plasma. Model 1 predicts that the second unlabelled dose will produce a secondary release of labelled vitamin C which will not be observed on the basis of Model 2. In all subjects Model 1 failed to predict the observed plasma concentration profiles for labelled and unlabelled vitamin C, but Model 2 fitted the experimental observations. We speculate on possible physiological explanations for this behaviour, but from the limited information available cannot unequivocally confirm the model structure by identifying the source of the supposed flux.

Download full-text PDF

Source
http://dx.doi.org/10.1079/bjn20051369DOI Listing

Publication Analysis

Top Keywords

labelled unlabelled
12
unlabelled vitamin
8
model ingested
8
ingested vitamin
8
vitamin
7
model
7
labelled
5
'anomalous' absorption
4
absorption labelled
4
unlabelled
4

Similar Publications

Dual-view global and local category-attentive domain alignment for unsupervised conditional adversarial domain adaptation.

Neural Netw

January 2025

School of Computer Engineering and Science, Shanghai University, Shanghai, 200444, China. Electronic address:

Conditional adversarial domain adaptation (CADA) is one of the most commonly used unsupervised domain adaptation (UDA) methods. CADA introduces multimodal information to the adversarial learning process to align the distributions of the labeled source domain and unlabeled target domain with mode match. However, CADA provides wrong multimodal information for challenging target features due to utilizing classifier predictions as the multimodal information, leading to distribution mismatch and less robust domain-invariant features.

View Article and Find Full Text PDF

Community isolation of patients with communicable infectious diseases limits spread of pathogens but our understanding of isolated patients' needs and challenges is incomplete. Rwanda deployed a digital health service nationally to assist public health clinicians to remotely monitor and support SARS-CoV-2 cases via their mobile phones using daily interactive short message service (SMS) check-ins. We aimed to assess the texting patterns and communicated topics to better understand patient experiences.

View Article and Find Full Text PDF

SD-LayerNet: Robust and label-efficient retinal layer segmentation via anatomical priors.

Comput Methods Programs Biomed

January 2025

Christian Doppler Laboratory for Artificial Intelligence in Retina, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria; Institute of Artificial Intelligence, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.

Background And Objectives: Automated, anatomically coherent retinal layer segmentation in optical coherence tomography (OCT) is one of the most important components of retinal disease management. However, current methods rely on large amounts of labeled data, which can be difficult and expensive to obtain. In addition, these systems tend often propose anatomically impossible results, which undermines their clinical reliability.

View Article and Find Full Text PDF

Antibody-based pharmaceuticals are the leading biologic drug platform (> $75B/year). Despite a wealth of information collected on them, there is still a lack of knowledge on their inter-domain structural distributions, which impedes innovation and development. To address this measurement gap, we have developed a new methodology to derive biomolecular structure ensembles from distance distribution measurements via a library of tagged proteins bound to an unlabeled and otherwise unmodified target biologic.

View Article and Find Full Text PDF

Radiolabeling of Siamenoside I with Carbon-14.

Org Lett

January 2025

The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, Georgia 30313, United States.

The synthesis of radiolabeled [25-C]-siamenoside I following a synthetic route developed using unlabeled materials is disclosed. The synthesis features an early stage labeling of the mogrol's C25 an oxidative cleavage-reconstruction strategy and regioselective glycosylations directed by protecting group manipulations. This route provided access to adequate amounts of [25-C]-siamenoside I for ADME and PK studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!